ZBH

98.20

2.43% -2.45

Handel nachbörslich: 98.20

Zimmer Biomet Holdings Inc (ZBH)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Dividendenhistorie

Schlusskurs vom Vortag:

$100.65

Offen:

$99.78

24-Stunden-Volumen:

1.75M

Relative Volume:

0.74

Marktkapitalisierung:

$18.73B

Einnahmen:

$8.41B

Nettoeinkommen (Verlust:

$760.80M

KGV:

25.50

EPS:

3.8513

Netto-Cashflow:

$1.05B

1W Leistung:

+0.43%

1M Leistung:

+7.77%

6M Leistung:

+1.08%

1J Leistung:

-4.43%

1-Tages-Spanne:

$97.87

$100.14

1-Wochen-Bereich:

$94.28

$101.16

52-Wochen-Spanne:

$79.12

$108.29

Zimmer Biomet Holdings Inc Stock (ZBH) Company Profile

Firmenname

Zimmer Biomet Holdings Inc

Sektor

Healthcare (1082)

Branche

Medical Devices (139)

Telefon

(574) 267-6131

Adresse

345 EAST MAIN STREET, WARSAW, IN

Mitarbeiter

17,000

Twitter

@zimmerbiomet

Nächster Verdiensttermin

2026-08-05

Neueste SEC-Einreichungen

ZBH's Discussions on Twitter

Compare ZBH vs ABT, SYK, MDT, BSX, EW

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
ZBH Zimmer Biomet Holdings Inc	98.20	19.20B	8.41B	760.80M	1.05B	3.8513
ABT Abbott Laboratories	110.37	192.51B	46.59B	5.41B	7.38B	3.0938
SYK Stryker Corp	331.68	130.11B	25.27B	3.34B	4.57B	8.6334
MDT Medtronic Plc	90.60	116.83B	36.36B	4.84B	5.43B	3.7261
BSX Boston Scientific Corp	51.43	75.11B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	90.81	52.80B	6.30B	1.07B	1.09B	1.8406

Zimmer Biomet Holdings Inc Stock (ZBH) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2026-03-23	Herabstufung	BTIG Research	Buy → Neutral
2026-02-20	Eingeleitet	William Blair	Mkt Perform
2026-01-09	Herabstufung	Goldman	Neutral → Sell
2026-01-06	Herabstufung	Raymond James	Outperform → Mkt Perform
2026-01-05	Hochstufung	Evercore ISI	In-line → Outperform
2025-12-16	Herabstufung	Robert W. Baird	Outperform → Neutral
2025-11-06	Herabstufung	JP Morgan	Overweight → Neutral
2025-09-18	Eingeleitet	Rothschild & Co Redburn	Buy
2025-07-15	Hochstufung	Roth Capital	Neutral → Buy
2024-12-17	Hochstufung	JP Morgan	Neutral → Overweight
2024-09-10	Eingeleitet	Wolfe Research	Peer Perform
2024-07-01	Herabstufung	Piper Sandler	Overweight → Neutral
2024-05-30	Eingeleitet	Goldman	Neutral
2024-05-21	Hochstufung	Argus	Hold → Buy
2024-01-04	Herabstufung	Evercore ISI	Outperform → In-line
2023-10-20	Eingeleitet	ROTH MKM	Neutral
2023-08-28	Hochstufung	BTIG Research	Neutral → Buy
2023-05-03	Hochstufung	BofA Securities	Underperform → Neutral
2023-04-11	Hochstufung	Evercore ISI	In-line → Outperform
2023-03-31	Hochstufung	Jefferies	Underperform → Hold
2023-03-29	Eingeleitet	UBS	Sell
2023-03-10	Hochstufung	Piper Sandler	Neutral → Overweight
2023-01-09	Hochstufung	RBC Capital Mkts	Sector Perform → Outperform
2023-01-05	Hochstufung	Raymond James	Mkt Perform → Outperform
2023-01-03	Herabstufung	Evercore ISI	Outperform → In-line
2022-11-23	Hochstufung	Wells Fargo	Underweight → Equal Weight
2022-10-18	Eingeleitet	Barclays	Underweight
2022-10-12	Eingeleitet	Jefferies	Underperform
2022-05-27	Herabstufung	Needham	Buy → Hold
2022-04-13	Herabstufung	Truist	Buy → Hold
2022-04-01	Herabstufung	Citigroup	Buy → Neutral
2022-03-02	Fortgesetzt	BofA Securities	Underperform
2022-03-02	Herabstufung	Loop Capital	Buy → Hold
2022-02-08	Herabstufung	Canaccord Genuity	Buy → Hold
2022-02-08	Bestätigt	Citigroup	Buy
2022-02-08	Bestätigt	Deutsche Bank	Hold
2022-02-08	Bestätigt	JMP Securities	Mkt Outperform
2022-02-08	Bestätigt	JP Morgan	Neutral
2022-02-08	Bestätigt	RBC Capital Mkts	Sector Perform
2022-02-08	Bestätigt	Stifel	Buy
2022-02-08	Bestätigt	Truist	Buy
2022-02-08	Bestätigt	UBS	Neutral
2022-02-08	Bestätigt	Wells Fargo	Underweight
2022-02-02	Herabstufung	UBS	Buy → Neutral
2022-01-19	Herabstufung	Wells Fargo	Equal Weight → Underweight
2022-01-10	Herabstufung	Mizuho	Buy → Neutral
2022-01-07	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2022-01-04	Herabstufung	Piper Sandler	Overweight → Neutral
2021-12-10	Eingeleitet	RBC Capital Mkts	Sector Perform
2021-12-09	Herabstufung	Needham	Strong Buy → Buy
2021-12-07	Eingeleitet	Loop Capital	Buy
2021-11-23	Herabstufung	Argus	Buy → Hold
2021-09-14	Fortgesetzt	Raymond James	Mkt Perform
2021-05-25	Eingeleitet	Barclays	Overweight
2021-04-09	Hochstufung	Northland Capital	Market Perform → Outperform
2021-01-04	Hochstufung	Evercore ISI	In-line → Outperform
2020-12-18	Bestätigt	Needham	Strong Buy
2020-10-20	Eingeleitet	Northland Capital	Market Perform
2020-09-11	Eingeleitet	Wolfe Research	Outperform
2020-08-05	Bestätigt	Needham	Strong Buy
2020-04-28	Herabstufung	Guggenheim	Buy → Neutral
2020-04-09	Herabstufung	Evercore ISI	Outperform → In-line
2020-04-07	Bestätigt	Needham	Strong Buy
2020-03-05	Eingeleitet	Citigroup	Buy
2020-02-13	Eingeleitet	Goldman	Buy
2020-01-08	Eingeleitet	SunTrust	Buy
2020-01-07	Hochstufung	Piper Jaffray	Neutral → Overweight
2020-01-07	Hochstufung	Piper Sandler	Neutral → Overweight
2019-12-04	Hochstufung	Raymond James	Outperform → Strong Buy
2019-10-07	Hochstufung	BTIG Research	Neutral → Buy
2019-09-18	Hochstufung	Canaccord Genuity	Hold → Buy
2019-08-12	Hochstufung	Argus	Hold → Buy
2019-07-30	Hochstufung	Barclays	Underweight → Equal Weight
2019-07-29	Hochstufung	Robert W. Baird	Neutral → Outperform
2019-06-11	Hochstufung	Bernstein	Underperform → Mkt Perform
2019-04-24	Hochstufung	Needham	Buy → Strong Buy

Alle ansehen

Zimmer Biomet Holdings Inc Aktie (ZBH) Neueste Nachrichten

Aug 17, 2026

Zimmer Biomet Holdings Inc. stock underperforms Monday when compared to competitors - MarketWatch

Aug 17, 2026

Zimmer Biomet stock edges lower as investors weigh Q2 2026 cash flow and $1 billion buyback plan - ad-hoc-news.de

Aug 17, 2026

297,894 Shares in Zimmer Biomet Holdings, Inc. $ZBH Bought by Alberta Investment Management Corp - MarketBeat

Aug 17, 2026

Aug 16, 2026

Zimmer Biomet Holdings (ZBH) Could Be 2% Undervalued As Q2 Beat Lifts The Story - Sahm

Aug 16, 2026

Aug 15, 2026

Everett Harris & Co. CA Invests $2.55 Million in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat

Aug 15, 2026

Aug 14, 2026

Chintan Desai Net Worth (2026) - GuruFocus

Aug 14, 2026

Zimmer Biomet Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch

Aug 14, 2026

Will Zimmer Biomet’s Upgraded 2026 Guidance and Buyback Shift Zimmer Biomet Holdings’ (ZBH) Narrative - Sahm

Aug 14, 2026

SYK Stock Gains 3.8% Since March-End: What's Driving the Uptrend? - TradingView

Aug 14, 2026

Are Wall Street Analysts Bullish on Zimmer Biomet Stock? - Barchart.com

Aug 14, 2026

5 Revealing Analyst Questions From Zimmer Biomet’s Q2 Earnings Call - Yahoo Finance

Aug 14, 2026

Handelsbanken Fonder AB Buys 28,130 Shares of Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat

Aug 14, 2026

Aug 13, 2026

Zimmer Biomet (ZBH) sees Dodge & Cox disclose 12.5% ownership stake - Stock Titan

Aug 13, 2026

Stryker Up 13.6% in 3 Months as Recovery Gains Strength, What's Next? - TradingView

Aug 13, 2026

Zimmer Biomet reports strong second quarter financial results - Today's Medical Developments

Aug 13, 2026

Aug 12, 2026

Donald TrumpZIMMER BIOMET HOLDINGS INC Trump Trade on May. 11, 2026 - Quiver Quantitative

Aug 12, 2026

Zimmer Biomet (ZBH): Capital International Investors reports 6.4% ownership stake - Stock Titan

Aug 12, 2026

Assenagon Asset Management S.A. Buys 97,887 Shares of Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat

Aug 12, 2026

Aug 10, 2026

Zimmer Biomet (NYSE:ZBH) Price Target Raised to $100.00 - MarketBeat

Aug 10, 2026

Price to earnings forward of Zimmer Biomet Holdings, Inc. – NYSE:ZBH - tradingview.com

Aug 10, 2026